When you’re looking for a stock sector with potential for big gains, you can’t help but look at the biotechs. These stocks are famous for their long product lead times and high overhead – bringing a new pharmaceutical to market can take years, and cost tens of millions of dollars – but for investors, their attraction lies in their potential. One piece of good news, be it a positive clinical trial result or meeting a regulatory milestone, can give a major boost to the share price. The trick is fi
Are we headed for a soft landing? That would be the best-case resolution to the current cycle of high inflation and high interest rates, and several indicators are flashing ‘yes.’ The ongoing earnings season, bringing us results from 4Q23, is beating expectations, showing an overall 5.2% year-over-year boost, against the 1.3% expectation. Stocks are responding with solid gains, and the S&P 500 has been hitting record highs. Meanwhile, in difficult circumstances, the economy has been showing it i
Are penny stocks a must-have or a must-avoid? Well, that depends on who you ask. There’s no middle ground when it comes to these tickers trading for less than $5 per share; those on the Street are either fans or harsh critics. Both sides make sense. The naysayers argue that the bargain price is just too good to be true, with it potentially indicating there are problems hiding beneath the surface like weak fundamentals or overwhelming headwinds. However, the investors that are pro-penny stocks ju
In the face of a challenging macro backdrop, Roku (NASDAQ:ROKU) has performed well over the past year. It has frequently beaten analyst expectations, and its Q3 print featured more new users coming on board than had been expected, the successful implementation of cost cutting measures and a guide that called for positive EBITDA in Q4 and 2024. With the streaming video platform about to deliver its Q4 results (Thursday, February 15, after the markets close), Wedbush analyst Alicia Reese thinks a
Dow Jones futures, S&P 500 futures and Nasdaq 100 futures were lower ahead of the stock market open on Tuesday. Head of stock market hand (ARM) hit a new